1. Refractory Chest Pain in Mild to Moderate Coronavirus Disease 2019 Successfully Treated with Saikanto, a Japanese Traditional Medicine
   Ryutaro Arita et al, 2022, The Tohoku Journal of Experimental Medicine CrossRef
2. Berberine Attenuates IL-1β-Induced Damage of Nucleus Pulposus Cells via Activating the AMPK/mTOR/Ulk1 Pathway
   Liaoyuan Huang et al, 2022, BioMed Research International CrossRef
3. Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals
   Liang Kang et al, 2022, Frontiers in Pharmacology CrossRef
4. Huang-Lian-Jie-Du Decoction Ameliorates Acute Ulcerative Colitis in Mice via Regulating NF-κB and Nrf2 Signaling Pathways and Enhancing Intestinal Barrier Function
   Ziwen Yuan et al, 2019, Frontiers in Pharmacology CrossRef
5. Natural Products of Pharmacology and Mechanisms in Nucleus Pulposus Cells and Intervertebral Disc Degeneration
   Hai-Wei Chen et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Natural products can modulate inflammation in intervertebral disc degeneration
   Zongtai Liu et al, 2023, Frontiers in Pharmacology CrossRef
7. Botanical Drug Extracts Combined With Biomaterial Carriers for Osteoarthritis Cartilage Degeneration Treatment: A Review of 10 Years of Research
   Panyun Mu et al, 2022, Frontiers in Pharmacology CrossRef
8. Cationic Polymer Brush-Modified Carbon Nanotube-Meditated eRNA LINC02569 Silencing Attenuates Nucleus Pulposus Degeneration by Blocking NF-κB Signaling Pathway and Alleviate Cell Senescence
   Yulin Huang et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
9. Hesperidin mitigates oxidative stress-induced ferroptosis in nucleus pulposus cells via Nrf2/NF-κB axis to protect intervertebral disc from degeneration
   Jian Zhu et al, 2023, Cell Cycle CrossRef
10. Mesenchymal Stem Cell-Derived Exosomes as a Novel Strategy for the Treatment of Intervertebral Disc Degeneration
    Lin Lu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
11. Targeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration
    Md Entaz Bahar et al, 2022, Antioxidants CrossRef
12. Drug Delivery Systems for Intervertebral Disc
    Isma Liza Mohd Isa et al, 2024, Drug Delivery Systems for Musculoskeletal Tissues CrossRef
13. Anti-inflammatory Response and Detection of Pharmacologically Active Components in Serum of Rats with Carrageenan-Induced Paw Swelling Treated with Phellodendron chinense
    Le Shi et al, 2023, Revista Brasileira de Farmacognosia CrossRef
14. Intervertebral disc degeneration and inflammatory microenvironment: expression, pathology, and therapeutic strategies
    Xin Chen et al, 2023, Inflammation Research CrossRef
15. From drugs to biomaterials: a review of emerging therapeutic strategies for intervertebral disc inflammation
    Shuhan Yang et al, 2024, Frontiers in Cellular and Infection Microbiology CrossRef
16. Current status and development direction of immunomodulatory therapy for intervertebral disk degeneration
    Yanbing Gao et al, 2023, Frontiers in Medicine CrossRef
17. Mesenchymal Stem Cell-Derived Exosomes and Intervertebral Disc Regeneration: Review
    Basanta Bhujel et al, 2022, International Journal of Molecular Sciences CrossRef
18. Ulinastatin Ameliorates IL-1β-Induced Cell Dysfunction in Human Nucleus Pulposus Cells via Nrf2/NF-κB Pathway
    Xi Luo et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
19. Berberine regulates bone metabolism in apical periodontitis by remodelling the extracellular matrix
    Yujia Cui et al, 2023, Oral Diseases CrossRef
20. Recent Advances in Managing Spinal Intervertebral Discs Degeneration
    Bogdan Costăchescu et al, 2022, International Journal of Molecular Sciences CrossRef
21. Cytokines and neoangiogenesis parameters in young patients with acute discogenic lumbosacral radiculopathy
    M. Yu. Maksimova et al, 2022, Russian neurological journal CrossRef